logo
搜索
菜单

视频 在线看

当前1165/1397页
排序: 今日浏览数
13.1: Drug Dosing: Infants and Children 01:29 min
13.1: Drug Dosing: Infants and Children
12.15: Therapeutic Drug Monitoring: Affecting Factors 01:29 min
12.15: Therapeutic Drug Monitoring: Affecting Factors
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.13: IV Infusion to Oral Dosing: Conversion Methods 01:28 min
12.13: IV Infusion to Oral Dosing: Conversion Methods
12.9: Drug Accumulation During Multiple Dosing: Intermittent IV Infusions 01:24 min
12.9: Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
12.7: Dosage Interval and Administration Route: Determination Methods 01:19 min
12.7: Dosage Interval and Administration Route: Determination Methods
12.4: Dosage Regimen: Individualization 01:24 min
12.4: Dosage Regimen: Individualization
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters 01:01 min
12.2: Dosage Regimens: Partial Pharmacokinetic Parameters
12.1: Dosage Regimens: Designs and Approaches 01:28 min
12.1: Dosage Regimens: Designs and Approaches
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications 01:09 min
11.5: Bioequivalence of Drugs: Drugs with Multiple Indications
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence 01:19 min
11.3: Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
11.2: Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence 01:22 min
11.2: Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
11.1: Pharmaceutical Equivalents 01:26 min
11.1: Pharmaceutical Equivalents
10.9: Drug Product Stability 01:16 min
10.9: Drug Product Stability
10.8: Clinically Relevant Drug Product Specifications: Methods of Establishment 01:29 min
10.8: Clinically Relevant Drug Product Specifications: Methods of Establishment
10.4: In Vitro Drug Dissolution: Compendial Testing Models II 01:09 min
10.4: In Vitro Drug Dissolution: Compendial Testing Models II
10.3: In Vitro Drug Dissolution: Compendial Testing Models I 01:13 min
10.3: In Vitro Drug Dissolution: Compendial Testing Models I
10.2: In Vitro Drug Release Testing: Overview, Development and Validation 01:10 min
10.2: In Vitro Drug Release Testing: Overview, Development and Validation
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview 01:22 min
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview
9.17: Drug Products: Biologics, Biosimilars and Interchangeables 01:28 min
9.17: Drug Products: Biologics, Biosimilars and Interchangeables
返回顶部